CTRI/2022/09/045622尚未招募不适用
A clinicopathological study of carcinoma stomach in a tertiary care centre in Chengalpattu district.
Melmaruvathur Adhiparasakthi Institute Of Medical Sciences And Research1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2022年9月20日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- studying the clinical and pathological outcomes in carcinoma stomach
研究概览
简要总结
THIS IS A CASE CONTROL STUDY,TO ASSESS THE STAGING AND SURGICAL MODALITIES OF TREATMENT AND COMPARE THE RESULTS OF CA STOMACH IN CHENGALPATTU DISTRICT.PRIMARY OUTCOME WILL BE BASED ON THE CLINICAL AND PATHOLOGICAL RESULTS.SECONDARY OUTCOME WILL BE THE RESPONSE TO TREATMENT
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •patient who belongs to the age group between 20 to 99 years.
排除标准
- •recurrent carcinoma stomach.
结局指标
主要结局
studying the clinical and pathological outcomes in carcinoma stomach
时间窗: baseline, 2 weeks and 4 weeks
次要结局
- response to the treatment(4 weeks and 8 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A clinical study of stomach cancer in a tertiary care centre in Chengalpattu district.CTRI/2022/09/045622Melmaruvathur Adhiparasakthi Institute Of Medical Sciences And Research
尚未招募
不适用
Prospective Observational Cohort StudyLiver MetastasesGastric CancerNCT06493448Lin Chen1,326
已完成
3 期
Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA TrialGastric CancerNCT00941655National Cancer Institute (NCI)15
已完成
不适用
Study of tumor markers in terms of their importance in the grade and stage of stomach cancer.CTRI/2021/05/033905Chittaranjan National Cancer Institute63
已完成
不适用
Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in CanadaUpper Gastrointestinal CancerNCT06361563Bristol-Myers Squibb250